Gnao1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@dy2015]
| Attribute | Value | |-----------|-------| | Protein Name | G Protein Subunit Alpha O1 (Gαo1) | | Gene Symbol | GNAO1 | | UniProt ID | [P71275](https://www.uniprot.org/uniprot/P71275) | | Molecular Weight | ~40 kDa | | Subcellular Localization | Plasma membrane, Cytoplasm | | Protein Family | Gαo family (GPCR signaling) | | Brain Expression | Very High (Cortex, Hippocampus, Cerebellum) |
</div>}
Overview
The GNAO1 gene encodes the G protein subunit alpha O1 (Gαo1), one of the most abundant Gα subunits in the brain. Gαo is the major effector of many neurotransmitters and plays critical roles in neuronal signaling, synaptic transmission, and various brain functions. Mutations in GNAO1 cause early-onset epileptic encephalopathy and movement disorders.
Molecular Function
GPCR Signaling
Gαo couples to Gi/o-coupled receptors:
Adenylate Cyclase Inhibition: Reduces cAMP production
Phospholipase C Modulation: Affects IP3/DAG signaling
Ion Channel Regulation: Modulates calcium and potassium channels
Gnao1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@dy2015]
| Attribute | Value | |-----------|-------| | Protein Name | G Protein Subunit Alpha O1 (Gαo1) | | Gene Symbol | GNAO1 | | UniProt ID | [P71275](https://www.uniprot.org/uniprot/P71275) | | Molecular Weight | ~40 kDa | | Subcellular Localization | Plasma membrane, Cytoplasm | | Protein Family | Gαo family (GPCR signaling) | | Brain Expression | Very High (Cortex, Hippocampus, Cerebellum) |
</div>}
Overview
The GNAO1 gene encodes the G protein subunit alpha O1 (Gαo1), one of the most abundant Gα subunits in the brain. Gαo is the major effector of many neurotransmitters and plays critical roles in neuronal signaling, synaptic transmission, and various brain functions. Mutations in GNAO1 cause early-onset epileptic encephalopathy and movement disorders.
Molecular Function
GPCR Signaling
Gαo couples to Gi/o-coupled receptors:
Adenylate Cyclase Inhibition: Reduces cAMP production
Phospholipase C Modulation: Affects IP3/DAG signaling
Ion Channel Regulation: Modulates calcium and potassium channels
Calcium Dysregulation: Gαo effect on calcium channels
Parkinson's Disease
Dopamine Signaling: Modulation of D2 receptor signaling
Motor Complications: Potential role in dyskinesias
Therapeutic Implications
Treatment Approaches
| Approach | Target | Status | |----------|--------|--------| | Antiepileptics | Seizure control | Standard care | | Deep Brain Stimulation | Movement symptoms | Effective | | Gene Therapy | GNAO1 | Research | | Small Molecule Modulators | Gαo signaling | Preclinical |
Research Directions
Mechanism Studies: How mutations cause disease
Model Systems: iPSC-derived [neurons](/entities/neurons)
Therapeutic Screening: Drug discovery
Key Publications
PMID: 23674376(https://pubmed.ncbi.nlm.nih.gov/23674376/) - GNAO1 mutations in epileptic encephalopathy
PMID: 25807384(https://pubmed.ncbi.nlm.nih.gov/25807384/) - GNAO1 and movement disorders
Therapeutic Implications
Target Overview
GNAO1 represents a promising therapeutic target due to its central role in neuronal signaling. The Gαo subunit is the most abundant G-protein in the brain, making it an attractive target for neurological disorders.
Subunit selectivity important for avoiding side effects
Regional targeting may reduce adverse effects
Animal Models
Knockout Studies
Gnao1-/- mice exhibit:
Lethal phenotype (perinatal)
Severe neurological deficits
Impaired synaptic transmission
Learning and memory defects
Conditional Knockouts
Conditional deletion in adult mice shows:
Progressive neurodegeneration
Motor coordination deficits
Seizure susceptibility
Altered reward processing
Background
The study of Gnao1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.